Evidence map›Paper›PMID 34672382›Full record

ArticleUltrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology2022

Comorbidity, poverty and social vulnerability as risk factors for mortality in pregnant women with confirmed SARS-CoV-2 infection: analysis of 13 062 positive pregnancies including 176 maternal deaths in Mexico.

J Torres-Torres, R J Martinez-Portilla, S Espino-Y-Sosa, G Estrada-Gutierrez, J M Solis-Paredes, J R Villafan-Bernal, V Medina-Jimenez, A J Rodriguez-Morales, L Rojas-Zepeda, L C Poon

Open access · greenAbstract read
In one paragraph

Article in Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. [Hypertensive disorders of pregnancy in women with COVID-19].Archives des maladies du coeur et des vaisseaux. Pratique · 2022
    Review
  14. Emotional State of Mexican University Students in the COVID-19 Pandemic.International journal of environmental research and public health · 2022
    Article
  15. Does COVID-19 cause pre-eclampsia?Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · 2022
    Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 5 countries.

J Torres-TorresMaternal-Fetal Medicine Department, General Hospital of Mexico, 'Dr Eduardo Liceaga', Mexico City, Mexico.
R J Martinez-PortillaClinical Research Branch, National Institute of Perinatology, Mexico City, Mexico.ORCID 0000-0003-4711-3857
S Espino-Y-SosaClinical Research Branch, National Institute of Perinatology, Mexico City, Mexico.
G Estrada-GutierrezResearch Direction, National Institute of Perinatology, Mexico City, Mexico.
J M Solis-ParedesClinical Research Branch, National Institute of Perinatology, Mexico City, Mexico.
J R Villafan-BernalLaboratory of Immunogenomics and Metabolic Diseases, INMEGEN, Mexico City, Mexico.
V Medina-JimenezABC Medical Center, Medical Association, Mexico City, Mexico.
A J Rodriguez-MoralesClinical Epidemiology and Biostatistics, Universidad Científica del Sur, Lima, Peru.
L Rojas-ZepedaInstituto Materno Infantil del Estado de México, Toluca, Mexico.
L C PoonDepartment of Obstetrics and Gynaecology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR.ORCID 0000-0002-3944-4130
Instituto Nacional de Perinatología · MXCentro Médico ABC · MXChinese University of Hong Kong · HKHospital General de México · MXInstituto de Salud del Estado de México · MXNational Institute of Genomic Medicine · MXUniversidad Científica del Sur · PE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveMortality in pregnancy due to coronavirus disease 2019 (COVID-19) is a current health priority in developing countries. Identification of clinical and sociodemographic risk factors related to mortality in pregnant women with COVID-19 could guide public policy and encourage such women to accept vaccination. We aimed to evaluate the association of comorbidities and socioeconomic determinants with COVID-19-related mortality and severe disease in pregnant women in Mexico.

methodsThis is an ongoing nationwide prospective cohort study that includes all pregnant women with a positive reverse-transcription quantitative polymerase chain reaction result for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from the Mexican National Registry of Coronavirus. The primary outcome was maternal death due to COVID-19. The association of comorbidities and socioeconomic characteristics with maternal death was explored using a log-binomial regression model adjusted for possible confounders.

resultsThere were 176 (1.35%) maternal deaths due to COVID-19 among 13 062 consecutive SARS-CoV-2-positive pregnant women. Maternal age, as a continuous (adjusted relative risk (aRR), 1.08 (95% CI, 1.05-1.10)) or categorical variable, was associated with maternal death due to COVID-19; women aged 35-39 years (aRR, 3.16 (95% CI, 2.34-4.26)) or 40 years or older (aRR, 4.07 (95% CI, 2.65-6.25)) had a higher risk for mortality, as compared with those aged < 35 years. Other clinical risk factors associated with maternal mortality were pre-existing diabetes (aRR, 2.66 (95% CI, 1.65-4.27)), chronic hypertension (aRR, 1.75 (95% CI, 1.02-3.00)) and obesity (aRR, 2.15 (95% CI, 1.46-3.17)). Very high social vulnerability (aRR, 1.88 (95% CI, 1.26-2.80)) and high social vulnerability (aRR, 1.49 (95% CI, 1.04-2.13)) were associated with an increased risk of maternal mortality, while very low social vulnerability was associated with a reduced risk (aRR, 0.47 (95% CI, 0.30-0.73)). Being poor or extremely poor were also risk factors for maternal mortality (aRR, 1.53 (95% CI, 1.09-2.15) and aRR, 1.83 (95% CI, 1.32-2.53), respectively).

conclusionThis study, which comprises the largest prospective consecutive cohort of pregnant women with COVID-19 to date, has confirmed that advanced maternal age, pre-existing diabetes, chronic hypertension, obesity, high social vulnerability and low socioeconomic status are risk factors for COVID-19-related maternal mortality. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.

Indexed as

Social VulnerabilityAdultCohort StudiesComorbidityCOVID-19FemaleHumansMaternal DeathMaternal MortalityMexicoPovertyPregnancyPregnancy Complications, InfectiousPremature BirthProspective StudiescomorbidityCOVID-19maternal deathpovertyvaccine

Identifiers

PMID34672382
PMCPMC8662032
OpenAlexW3207042316

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.